Passage Bio Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: PASG
Share price (9/29/26): $4.63
Market cap (9/29/26): $14.9 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 94 pages Amended and Restated Agreement and Plan of Merger by and Among: Passage Bio, Inc.; Peregrine Merger Sub, Inc.; Peregrine Merger Sub II, LLC and Remix Therapeutics, Inc. Dated as of September 2, 2026

from 425 94 pages Amended and Restated Agreement and Plan of Merger by and Among: Passage Bio, Inc.; Peregrine Merger Sub, Inc.; Peregrine Merger Sub II, LLC and Remix Therapeutics, Inc. Dated as of September 2, 2026

from 425 119 pages Agreement and Plan of Merger by and Among: Passage Bio, Inc.; Peregrine Merger Sub, Inc.; and Remix Therapeutics, Inc. Dated as of June 24, 2026

from 8-K 119 pages Agreement and Plan of Merger by and Among: Passage Bio, Inc.; Peregrine Merger Sub, Inc.; and Remix Therapeutics, Inc. Dated as of June 24, 2026